WWWaylon M. Weber

Waylon M. Weber

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Waylon M. Weber has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Quantitative Metabolomic Analysis of Urinary Citrulline and Calcitroic Acid in Mice after Exposure to Various Types of Ionizing Radiation

    by Maryam Goudarzi, Siddheshwar Chauthe, Steven J. Strawn, Waylon M. Weber, David J. Brenner, Albert J. Fornace

    With the safety of existing nuclear power plants being brought into question after the Fukushima disaster and the increased level of concern over terrorism-sponsored use of improvised nuclear devices, it is more crucial to develop well-defined radiation injury markers in easily accessible biofluids to help emergency-responders with injury assessment during patient triage. Here, we focused on utilizing ultra performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) to identify and quantitate the unique changes in the urinary excretion of two metabolite markers, calcitroic acid and citrulline, in mice induced by different forms of irradiation; X-ray irradiation at a low dose rate (LDR) of 3.0 mGy/min and a high dose rate (HDR) of 1.1 Gy/min, and internal exposure to Cesium-137 (137Cs) and Strontium-90 (90Sr). The multiple reaction monitoring analysis showed that, while exposure to 137Cs and 90Sr induced a statistically significant and persistent decrease, similar doses of X-ray beam at the HDR had the opposite effect, and the LDR had no effect on the urinary levels of these two metabolites. This suggests that the source of exposure and the dose rate strongly modulate the in vivo metabolomic injury responses, which may have utility in clinical biodosimetry assays for the assessment of exposure in an affected population. This study complements our previous investigations into the metabolomic profile of urine from mice internally exposed to 90Sr and 137Cs and to X-ray beam radiation.


  • Open Access

    Effect of 90Sr internal emitter on gene expression in mouse blood

    by Shanaz A. Ghandhi, Waylon Weber, Dunstana Melo, Melanie Doyle-Eisele, Mashkura Chowdhury, Raymond Guilmette, Sally A. Amundson

    The radioactive isotope Strontium-90 (90Sr) may be released as a component of fallout from nuclear accidents, or in the event of a radiological incident such as detonation of an improvised nuclear device, and if ingested poses a significant health risk to exposed individuals. In order to better understand the response to 90Sr, using an easily attainable and standard biodosimetry sample fluid, we analyzed the global transcriptomic response of blood cells in an in vivo model system. We injected C57BL/6 mice with a solution of 90SrCl2 and followed them over a 30-day period. At days 4, 7, 9, 25 and 30, we collected blood and isolated RNA for microarray analyses. These days corresponded to target doses in a range from 1–5 Gy. We investigated changes in mRNA levels using microarrays, and changes in specific microRNA (miRNA) predicted to be involved in the response using qRT-PCR. We identified 8082 differentially expressed genes in the blood of mice exposed to 90Sr compared with controls. Common biological functions were affected throughout the study, including apoptosis of B and T lymphocytes, and atrophy of lymphoid organs. Cellular functions such as RNA degradation and lipid metabolism were also affected during the study. The broad down regulation of genes observed in our study suggested a potential role for miRNA in gene regulation. We tested candidate miRNAs, mmu-miR-16, mmu-miR-124, mmu-miR-125 and mmu-mir-21; and found that all were induced at the earliest time point, day 4. Our study is the first to report the transcriptomic response of blood cells to the internal emitter 90Sr in mouse and a possible role for microRNA in gene regulation after 90Sr exposure. The most dramatic effect was observed on gene expression related to B-cell development and RNA maintenance. These functions were affected by genes that were down regulated throughout the study, suggesting severely compromised antigen response, which may be a result of the deposition of the radioisotope proximal to the hematopoietic compartment in bone.


  • Biokinetics of Systemically Distributed 60Co in the Rat

    by Waylon Weber, Melanie Doyle-Eisele, Steven K. Seilkop, Raymond Guilmette

    LBERI, a member of the Medical Countermeasures to Radiologic Threats (MCART) consortium funded by NIAID, was tasked to develop biokinetic models for the distribution of radionuclide threats using the most likely routes of incorporation in both small and large animals. In this paper, the biokinetics of systemically administered soluble 60Co have been examined. Male and female jugular-vein-catheterized (JVC) F344 rats received intravenous (IV) doses of 11.2 kBq of 60CoCl2. The distribution of the radiocobalt was followed for 28 d with tissue sampling done at 1 and 4 h, and at 1, 2, 4, 8, 16, and 28 d. Urine and feces were collected daily. Tissues and excreta were analyzed by gamma pulse height analysis. Within 8 d, 93% of the cobalt was eliminated from the body, primarily though urine. The highest tissue burdens were found in the liver, gastrointestinal (GI) tract, and muscle shortly after administration. These tissues cleared quickly, so that by the conclusion of the 28-d study, less than 3% of the injected dose remained in the body. The results are comparable to published literature values for tissue content of 60Co and for excretion patterns up to 30 d after injection. These results will provide the data needed to construct a biokinetic model for the unperturbed biokinetics of 60Co in rats, which will subsequently be used to evaluate the impact of administered decorporating agents on organ radiation doses. The animal model described in this paper is representative of that used for other routes of radionuclide administration, such as inhalation, ingestion, and wound contamination, that have been studied at LBERI in support of the MCART and NIAID programs.


  • Dermal and ocular exposure systems for the development of models of sulfur mustard-induced injury

    by Waylon M. Weber, Dean A. Kracko, Mericka R. Lehman, Christopher E. Cox, Yung-Sung Cheng, Gary R. Grotendorst, Jacob D. McDonald

    Sulfur mustard (SM) is a chemical threat agent for which the effects have no current treatment. Due to the ease of synthesis and dispersal of this material, the need to develop therapeutics is evident. The present article details the techniques used to develop SM laboratory exposure systems for the development of animal models of ocular and dermal injury. These models are critical to enable evaluation of SM injury and therapeutics against that injury. Iterative trials were conducted to optimize dermal and ocular injury models in guinea pigs and rabbits respectively. The goal was a homogeneous and diffuse ocular and dermal injury that compares to the human injury. Dermal exposures were conducted by either a flow-past or static vapor cup system. Ocular exposures were conducted by a static exposure system. Ocular and dermal exposures were conducted with vaporized SM. Vapor concentrations increased with time in the dermal and ocular exposure systems but were stable with varying amounts of applied SM. A dermal deposition estimation study was also conducted. Deposited volumes increased with exposure time.


  • Inhalation exposure systems for the development of rodent models of sulfur mustard-induced pulmonary injury

    by Waylon M. Weber, Dean A. Kracko, Mericka R. Lehman, Clinton M. Irvin, Lee F. Blair, Richard K. White, Janet M. Benson, Gary R. Grotendorst, Yung-Sung Cheng, Jacob D. McDonald

    Sulfur mustard (SM) is a chemical threat agent for which its effects have no current treatment. Due to the ease of synthesis and dispersal of this material, the need to develop therapeutics is evident. The present manuscript details the techniques used to develop SM laboratory exposure systems for the development of animal models of pulmonary injury. These models are critical for evaluating SM injury and developing therapeutics against that injury. Iterative trials were conducted to optimize a lung injury model. The resulting pathology was used as a guide, with a goal of effecting homogeneous and diffuse lung injury comparable to that of human injury. Inhalation exposures were conducted by either nose-only inhalation or intubated inhalation. The exposures were conducted to either directly vaporized SM or SM that was nebulized from an ethanol solution. Inhalation of SM by nose-only inhalation resulted in severe nasal epithelial degeneration and minimal lung injury. The reactivity of SM did not permit it to transit past the upper airways to promote lower airway injury. Intratracheal inhalation of SM vapors at a concentration of 5400 mg · min/m3 resulted in homogeneous lung injury with no nasal degeneration.


  • Disposition of tungsten in rodents after repeat oral and drinking water exposures

    by Waylon M. Weber, Rena Marr, Dean Kracko, Zhengyu Gao, Jacob D. McDonald, Kimberley Ui Chearnaigh

    Repeat oral doses of tungsten (W) show retention in kidneys, intestine, and femur as well as translocation of small amounts to neonates. Furthermore, W exposure leads to decreased function of molybdenum (Mo)-containing enzymes in kidneys, liver, and intestine. The chemical disposition of W (administered as sodium tungstate dihydrate in water) in plasma, liver, kidneys, uterus, femur, and intestine of rodents (Sprague-Dawley rats and C57Bl/6N mice) was characterized after repeat exposure by gavage (10 mg kg−1) or drinking water (560 mg L−1) for 14 consecutive days. Separately, the same species were exposed to drinking water (560 mg L−1) during gestation for 9 (mice) or 10 (rats) days. For the rodents exposed during gestation, all the aforementioned tissues were analyzed in addition to the fetus to assess transplacental disposition. Animals were euthanized 24 h after the last day of dosing. At sacrifice, plasma, intestine, liver, kidneys, femur, uterus, and fetus were collected for analysis by inductively coupled plasma mass spectrometry. W was detectable in plasma and all tissues and in fetus of both rats and mice. W accumulation occurred in intestine, kidneys, and femur. The possible sources for enrichment/retention in these tissues include the intestine being the primary route of entry for oral exposures, kidneys being the primary route of elimination (>95% excreted through the urine as shown in previous studies), and the ability of W to displace phosphate in bone and be retained in the femur. Enzyme activity of Mo-dependent enzymes xanthine oxidase (XO) and sulfite oxidase (SO) was also evaluated in liver, intestine, and kidneys due to the propensity of W to substitute for Mo. Enzyme activity was reduced in kidneys and intestine, while it was unaltered in liver.